Disclosure
Exponea negotiates a majority deal to buy out an early investor
“We're talking about majority deal because we believe that through this, we will onboard our original investor.”
Disclosure
Exponea targets over $100M in upcoming growth equity recapitalization
“Ah, actually, I think it's going to be even more. It's, we believe it's going to be north of a hundred.”
Disclosure
Exponea receives $200M preliminary valuation indications for its equity raise
“We're early on in the process and we only got some indications. The, and the indications were saying something around 200.”
Assertion Not checkable as stated
Exponea reaches $19M contracted ARR across roughly 195 customers
“So I, so we're at the nineteen million in CRR. So that gives you something like 195 customers, something like that.”
Prediction Not publicly verifiable
Irikovsky believes Exponea can reach over $200M revenue in 5-7 years
“We believe we can drive the company to over two hundred million in revenue in like five to seven years, because also the crisis is structurally playing strongly in our favor.”
Disclosure
Irikovsky promised Exponea staff no cost-cutting during the COVID-19 crisis
“We currently are burning money, and we, you know, gave everyone in the company a promise that we are not gonna do cost cutting. We're focused on ensuring that we pay the salaries to people.”
Assertion Supported
Exponea has raised over $35 million in total capital
“So we, we've raised over thirty five million.”
Assertion Not checkable as stated
Exponea's average contract value sits at $96,000 to $97,000 annually
“Hundred K. Just like 96, 97 is currently the average.”
Assertion Not checkable as stated
Exponea maintains 121% net retention, historically above 130%
“So our net retention, Has been long over 130. Now it's like 121%. And like we have a few contracts, expansion contracts that can drive it to 140% again.”
Assertion Not checkable as stated
Exponea reports a 12% annual gross revenue churn rate
“12% is the annual gross revenue churn.”
Disclosure
Irikovsky: Exponea is not profitable and would cut costs if fundraising fails
“So we're not profitable, but as our backup option is, we know that if we don't raise by the summer, we will have to take some cost cutting measures to make us profitable, but it wouldn't have to be very aggressive.”
Assertion Not checkable as stated
Exponea Has Over $5 Million Cash Remaining in Accounts
“We, we've got, if I remember correctly, we have got something over five.”
Assertion Not checkable as stated
Irikovsky: Exponea Burns Slightly Over $500K Per Month
“We are burning slightly more than 500 K per month.”
Assertion Not checkable as stated
Irikovsky: Exponea CAC Payback Is 21 Months Blended
“The return on CAG is on the blended average is 21 months. But if you look at some of the regions that are already well performing, we were just slightly over 12, which is what we want to achieve in all the markets once we, you know, go through the ramp up peri…”
Assertion Not checkable as stated
Exponea achieved 101% YoY revenue growth in 2019
“Year on over year growth for 2019 was 101%.”
Disclosure
COVID-19 caused enterprise buyers to postpone Exponea March deals
“Before COVID hit, we were expecting about 1.5 million. So that shows you that a lot of deals, they're not lost, but many are postponing the decision to see what's going to be happening.”
Assertion Not checkable as stated
Exponea saw investor interest at a $300M valuation in 2019
“We were able to get much higher valuations like, you know, a year back. We had several investors who were willing to pay, you know, 300.”
